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The doubly labelIed 65Zn-DTPAYC was injected into rats and the
urine assayed for Zn, 65Zn , and 14C. A simple quantitative method is
proposed which allows the metabolie fate of 65Zn to be derived. It has been
shown that the retention of 65Zn is mainly due to isotopic exchange whereas
the Zn-balance remains virtually unchanged. The exchangeable endogenous
Zn-pool was estimated to be 5·5 fLmoles . kg-\ i.e. 1 per cent of the t~tal body
Zn. The implication of these findings for the therapeutic usage ofZn-DTPA
is stressed.
1. INTRODUCTION
It has been shown by Catsch, Le and Chambault (1964) that the administra-
tion of Zn-DTPA (diethylenetriaminepentaacetic acid), labelIed by 65Zn, gives
rise to the retention of a certain fraction of 65 Zn by the rat. This may be
attributed either to a genuine deposition of Zn in tissue and/or to isotopic exchange.
The fact that a higher amount of previously administered 65 Zn can be removed
from the body by Zn-DTPA than by Ca-DTPA (Catsch and Le 1965) indicates
that isotopic exchange does actually occur, although the simultaneous splitting-off
and deposition of Zn cannot be excluded.
In view of the therapeutic use of DTPA in cases of poisoning with toxie or
radioactive metal ions, this question is of some practical importance as the thera-
peutic index (deflned as the ratio of toxic to therapeutic doses) of Zn-DTPA
proved to be essentially higher than that of Ca-DTPA (Catsch 1963, 1964a,
Catsch et al. 1964, Catsch and von Wedelstaedt 1965). The question whether
and to what extent a genuine retention of Zn is involved, is crucial because of
possible long-term side-effects of Zn.
The present study, using the doubly labelIed chelate 65 Zn-DTPA. l4C, is
based on the following conception :
The parenterally-administered chelate solution can be characterized by the
ratios 81 = 65 Zn/ Zn and 82 = Zn/14C. The corresponding ratios in the urine are
designated by VI and V 2• 8upposing that there is no retention of Zn and only
isotopic exchange between chelated 65 Zn and endogenous stable Zn takes place,
it is obvious that VI< 81 and V 2 = 8 2, The exchangeable fraction (Znex) of
the total endogenous Zn-pool can be derived from:
Znex = ZIltot(81/Ul -1), (1)
where the total dose of administered Zn is designated by Zntot, and Znex and
ZIltot have the same unit of measurement.
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If, on the other hand, there is retention of Zn and no isotopic exchange, we
obtain VI = SI and V 2 < S2' The retained fraction (Znret) is given by:
«.' ,Znret~'Zhtot0t-UJ2/S2j,? (2)
When both processes occur, the retained fraction of 65 Zn equals
65Zu"et='1- UIVidSlS2' (3)
Of course, we are aware thai other 'methods' are possible, for instance, the
determination of stable ;Zn and 6" Zn in the whole body. and·iIi theexcretions.
It is obvious, however, that such an experimental design is extremely laborious
and particularly susceptible to artefacts due to the contamination of urine by
Zn of spilled food, drinking water and faeces.
2. MEl'HoDs AND 'MATERIALS
Adult femal'e rats of theinbiedHeiligenberg-strain 'wereused, ,Before the
injection of DTPA into the cäudal vein, the urethra was tiedoff with a single
ligature. Four hours after th,e injection, the urine was sampledby puncturing the
bladder with asyringe equipped with a platinu,m ne,edle. l;3efore (but not during)
the experiment the animals had free access to drinking water and standard pellets
(20 fhg Zn. g-I). Preliminary experiments (see § 3) had shown that the bladder
contains, 4 hours following the intravenous injection of 0·5 ml. physiological
saline, 1·12 ±0·003 ml. of urine and that there is no marked back-pressure.
The following chemieals were used: (1) Na3 [Zn-DTPA] Ai H20 (by
courtesy of J.R. GeigyAG,·Basle); the excess of freeligand was :(; 0·2 per cent.
(2) DTPA .l4Cas acid (by courtesy oE Geigy Research Laböratories,'Atdsley,
N.Y.). The label is at the carboxylate groupings. The specific activity was
7·14fhCi. mg~l. (3) Metallic zinc (analytical grade) dissolved in conc.HCI with
a Zn-content :(; 5 x 10,--7 per cent. (4) Carrier free 65ZnC12 in 1 N HCI (The
Radiochemical Centre, Amersham).
The final solution was adjusted by NaOH to pR ~7. The injectedvolume
(O·Sml. per animal) contained 10fhmoles DTPA,9p,moles Zn, 14fhCi14C and
10 fhCi 65 Zn. The 10 per cent excess oe free ligand has been chosen purpose1y
since even a slight excess of unehelated Zn2+ would invalidate the experimental
results. For technical reasons (small volume and radioactivity of the solution)
the adjustment oE complete equivalance was not attempted.
The total amount of 'urine was immediately measmed and aliquots were
assayed for radioactivity. An amount of 0-02ml. wasapplied onafilter~paper
strip (width 4 cm, Schleicher & Schüll, No. 2043b). The ß-activityof thespots
(diam. ~ 17 mm) was measured by scanningthe paper strips at a constantspeed
(120 mm. h-1) between a dual windowless methane flowdetector ("'477 geometry).
The apertU'teofthe counters wasarectangular slit(l x 36 mm). The total activity
of thespots was determined bya btiilt-in integrator ofpeak intensity: The
y-activity of 65 Zn wasdeterminedby measuring the punched spots by a NaJ(Tl)-
crystalof the weH type: Irr order to obtiin the activity due to l~Conly,'acertain
fraction (corresponding ,to 65 Zn) was subtracted from the totalactivity. This
correction value was derived from measuringsamples of pure f:\5 Znunder identical
conditions by both counting equipments. The urine of each animal was assayed
in triplicate.. Thestandard error of the radiometrie measurements as estimated
by variance analysis of the data:was7:,5 pet cent and l'1 per cent for 14C arid 65Zn,
respectively.
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The urine was dry-ashed in platinum crucibles and analysed for Zn according
to the method of Vallee and Gibson (1948). The standard error of the Zn-
determination was found to be 3·5 per cent.
In order to avoid any contamination by external Zn, only highly purified
reagents were used. All glassware and syringes were made Zn-free by treatment
with disodium-Versenate and dithizone.
3. RESULTS AND DISCUSSION
In order to determine the urinary excretion of Zn in untreated animals under
our experimental conditions, 20 rats with an average body weight of 217 g were
injected with 0·5 ml. physiological saline. The average Zn-content of the 4 hour-
urine was 1·27±0·16p.g (1·13p.g.m1.-1 urine). This compares well with the
excretion of about 4p.g during 18 hours (MilIar, Fischer, Mawson and Elcoate
1954). The above value was subtracted from the actual Zn-amount of the urine
of DTPA-treated animals.
As can be seen from the table, about 75 per cent of DTPA.14C was excreted
within the first 4 hours. This is in keeping with pertinent data of Foreman (1960)
and Stevens, Rosoff, Weiner and Spencer (1962).
Body weight (g) 224±7
Urine:
Volume (mI.) 1·10 ± 0·12
65Zn (imp . sec-I. mI. -1 x 104) 1·447± 0·217
Zn (p.,g . mI. -1) 535 ±87
14C (imp. ml. -1 x 106) 2·218 ± 0·292
14C (percentage of dose) 73·3 ± 5·9
SI 30·62
U 1 26·94 ± 0·40
S2 (10-4) 2·124
U 2 (10-4) 2·282 ± 0·116
U 1 • U 2 (10-3) 6·140 ± 0·305
Znex (p,ffiol) 1·23 (0,91 ; l'57)t
Znret (fl,ffiol) -0,67 (0-40; -1'74)t
65Znret (percentage of dose) 5·6 (lS'8):I:
t Fiduciallimits for P=O·OS.
:I: Upper fiduciallimit for P=O·OS.
Averages ±S.E. (13 rats). For abbreviations see §1.
Since U 2/S2 is larger than unity equation (2) yields a negative figure. That
implies that there is no retention but rather a mobilization of endogeneous Zn.
The removed fraction amounts to 0·7 and maximum 1·7 p.moles. Keeping in
mind that the injected solution contained an excess of ,...., 1 p.mole free ligand, this
result is quite likely. Furthermore, it should not be forgotten that the octadenate
ligand can bind more than one Zn2+ (coordination number 4) and, thus, form
bimetallic chelate species of an appreciable stability (K~~2L"""10404, according to
Anderegg, Nägeli, Müller and Schwarzenbach 1959). The free capacity of the
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1 : 1 Zn-DTPA is also evident from the fact that the toxieity of the bimetallic
Zn2-TTHA (triethylenetetraaminehexa-acetic acid) is distinctly lower than
that of Zn-DTPA (von Wedelstaedt and Catsch 1965). Due to the relatively
broad fiducial range of the estimate for Znret, the assumption of a mobilizing
effect does not reach statistieal significance, and even the opposite case, i.e. the
retention of a maximum of 0·4 fkmoles, cannot be exc1uded.
On the other hand, the difference between SI and U 1 is highly signifieant.
The exchangeable endogenous Zn-pool, estimated aceording to equation (1),
equals 1·23 fkmoles. Referring to the data of Gilbert and Taylor (1956), the total
Zn-content of a rat with a body-weight of 224 g amounts to approximately
100 fkmoles, that of the soft tissues to about 65 fkmoles. Our estimate is distincdy
lower, but somewhat higher than the Zn-content of blood ( "",0·8 fkmoles). Thus,
we may deduce that the isotopic exchange is not restricted to the Zn of blood only.
The figure for the retention of 65 Zn, obtained by equation (3), is 6 per cent of
the administered dose and is in fairly good agreement with data obtained by direct
whole-body measurements (Catsch and Le, in press).
The results of the present investigation have two main implieations :
(i) They throw serious doubt on the possibility of interpeting the results of
experiments dealing with the metabolie fate of 65 Zn-ehelates (e.g. Foreman 1960,
Stand, Rosoff, Williams and Spencer 1962, Rosoff, Methfessel and Speneer 1965,
Spencer, Rosoff, Feldstein, Cohn and Gusmano 1965) in terms of a genuine
retention exc1usively. The same also applies, of course, to other radionuc1ides,
such as 60CO and 59Fe.
(ii) Following the intraperitoneal administration of Zn-DTPA with a
10 per cent excess of free ligand there is, if at a11, only a marginal retention of Zn
by the rat, amounting to a maximum of 1·8 fkmoles . kg-I. The parenteral
LD50 per cent of Zn in sma11 rodents is about 250-700 fkmoles. kg-I (Caujolle,
Chang, Mamy, Moulas and Suong 1964, Franz 1962). In humans an amount of
approximately 800 f-tmoles Zn is retained from anormal diet (McCance and
Widdowson 1942, Scoular 1939, Stern, Nadler and Earle 1941). An intravenous
dose of 8 f-tmoles Zn. kg-I (as gluconate) was found to be weIl tolerated (Vallee,
Fluharty and Gibson 1949). Finally it may be mentioned that the DTPA-dosage
used in the present study (45 fkmoles . kg-I) is in the same order of magnitude as
the one recommended for therapeutical purposes (Catsch 1964 b), i.e.
60 f-tmoles . kg-I . d-I . Taking into account a11 these facts the retention of
1·8 fkmoles Zn. kg-I (the worst estimate) can certainly be considered as safe.
Consequently, a possible argument against the therapeutic use of Zn-DTPA in
humans is invalidated. The question whether a higher amount of Zn will be
retained without an excess of free DTPA remains open. One should emphasize,
however, that an amount of 10 per cent free ligand in the dose-range used does
not lead to toxic side-effects (Catseh 1964 b ).
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On a injecte a des rats du 65Zn -DTPA.14C doublement marque et determine la teneur
en Zn, 65Zn et 14C des urines. Une methode quantitative simple est proposee pour suivre
le destin rnetabolique du 65Zn dans l'organisme. On a pu rnontrer que la retention du
65Zn est principalement dile a un echange isotopique, tandis que le bilan en Zn reste
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pratiquement inchange. La quantite de Zn endogene echangeable a pu etre estimee
a5,5 fLmoles •kg-r, soit 1 pour cent de la teneur totale en Zinc de l'organisme. On insiste
aussi sur la signification de ces constatations pour l'application therapeutique du Zn-DTPA.
Doppelt markiertes 65Zn-DTPA.14C wurde Ratten injiziert und der Gehalt des
Urins an Zn, 65Zn und 14C bestimmt. Es wird eine einfache quantitative Methode
vorgeschlagen, die gestattet, das Verhalten von 65Zn im Organismus zu erfassen. Eskonnte
gezeigt werden, daß die Retention von 65Zn im wesentlichen durch isotopischen Austausch
bedingt wird, während die Zn-Bilanz praktisch unverändert bleibt. Die austauschbare
endogene Zn-Fraktion konnte zu 5,5 fLmol. kg-r, d.h. rund 1 Prozent des gesamten
Körper-Zn, geschätzt werden. Es wird auf die sich aus diesen Befunden ergebenden
Konsequenzen für die therapeutische Verwendung von Zn-DTPA hingewiesen.
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